Log in to search using one of your social media accounts:

 

Abdominal Aortic Aneurysm (Symptoms, Repair, Surgery, Survival Rate)
Title: Abdominal Aortic Aneurysm (Symptoms, Repair, Surgery, Survival Rate)Category: Diseases and ConditionsCreated: 12/31/1997 12:00:00 AMLast Editorial Review: 11/15/2017 12:00:00 AM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - November 15, 2017 Category: Cardiology Source Type: news

Abdominal aortic aneurysm linked to dysregulated tryptophan metabolism, study finds
(Georgia State University) Researchers have found a link between dysregulated tryptophan metabolism and abdominal aortic aneurysm, a life-threatening vascular disease, according to a new study led by Georgia State University. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 13, 2017 Category: International Medicine & Public Health Source Type: news

Medtronic launches pivotal trial of Intrepid TMVR system
Medtronic (NYSE:MDT) said today it launched a pivotal trial of its Intrepid transcatheter mitral valve replacement system after winning FDA investigational device exemption for the device. The 1st patient in the trial was enrolled at Milwaukee’s Aurora St. Luke’s Medical Center, the Fridley, Minn.-based company said. The Apollo trial is slated to enroll up to 1,200 patients with severe, symptomatic mitral valve regurgitation into 2 cohorts with a primary endpoint of composite of all-cause mortality, all-stroke, reoperation or reintervention and cardiovascular hospitalization at 1 year. Secondary endpoints ...
Source: Mass Device - October 23, 2017 Category: Medical Devices Authors: Fink Densford Tags: Cardiac Implants Cardiovascular Catheters Clinical Trials Replacement Heart Valves Medtronic Source Type: news

This Device Has Been Around for 20 Years
It comes in different sizes and configurations now, but the Gore Excluder AAA Endoprosthesis, which seals off abdominal aneurysms from inside the aorta, hasn’t changed radically since it was introduced to the European market in 1997. The endovascular aneurysm repair (EVAR) device has been implanted in more than 300,000 patients diagnosed with an abdominal aortic aneurysm (AAA), according to its manufacturer, W.L. Gore & Associates. Before EVAR, patients with AAA had two options: major surgery to repair the aneurysm or crossed fingers. “The number of patients who were not candidates for surgery really drove ...
Source: MDDI - October 13, 2017 Category: Medical Devices Authors: Nancy Crotti Tags: Implants Design Source Type: news

Medtronic breaks ground on western China Innovation Center
Medtronic (NYSE:MDT) said today it has begun work on an Innovation Center in Chengdu, China, slated to open in 2020. The new Chengdu Innovation Center is being built at the Singapore-Sichuan Hi-Tech Innovation Park in the Sichuan Province and aims to provide clinical training and research platforms for medical workers in the region and neighboring regions. “Medtronic understands the critical role that rural physicians play in driving the healthcare availability and transformation. As such, we hope to support the growth and development of medical workers in China’s vast central and western regions, help the...
Source: Mass Device - October 10, 2017 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Medtronic Source Type: news

Medtronic wins expanded FDA nod for Endurant II stent graft
Medtronic (NYSE:MDT) said today it won expanded FDA approval for its Endurant II and IIs stent graft systems designed to treat abdominal aortic aneurysms, now indicated for use in combination with the Heli-FX EndoAnchor system to treat patients with short, hostile aortic neck anatomies. Prior to receiving the clearance, patients with short infra-renal necks were classified as ineligible for endovascular aneurysm repair, the Fridley, Minn.-based company said. Medtronic estimates that 10-13% of AAA patients have AAA proximal neck anatomies of lower than or equal to 10mm. “Due to the complex and hostile proximal ao...
Source: Mass Device - October 10, 2017 Category: Medical Devices Authors: Fink Densford Tags: Food & Drug Administration (FDA) Regulatory/Compliance Stents Vascular Medtronic Source Type: news

Endologix wins refined CE Mark indications for Nellix stent graft
Endologix (NSDQ:ELGX) said today it won expanded CE Mark approval in the European Union for its Nellix endovascular aneurysm sealing system with refined indications for use. The Irvine, Calif.-based company said that the refined indications for use were supported by clinical data and an independent clinical reviewer, and that the device met applicable safety and clinical performance requirements. “We are very pleased with the clinical outcomes generated by the Nellix EndoVascular Aneurysm Sealing System utilizing the refined IFU. The Nellix CE Mark with the refined IFU provides patients and physicians in Europe ...
Source: Mass Device - September 21, 2017 Category: Medical Devices Authors: Fink Densford Tags: Regulatory/Compliance Stent Grafts Vascular Endologix Source Type: news

Lombard touts expected 50% cost reduction in restructuring effort
Lombard Medical Technologies (NSDQ:EVAR) said today it completed a restructuring of its business after implementing a plan to focus its sales efforts on the UK, Japan and China, as well as reducing operating and manufacturing costs as it seeks to breakeven with its cash flow. The UK-based company said that the restructuring is expected to result in a reudction of nearly $12 million in operating expenses next year when compared to last years expenditure levels, with costs reduced more than 50%. “During 2017, we have refocused sales and marketing activities in an effort to concentrate on our highest margin markets...
Source: Mass Device - September 14, 2017 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News lombardmedical MicroPort Scientific Source Type: news

MassDevice.com +5 | The top 5 medtech stories for September 14, 2017
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry. Get this in your inbox everyday by subscribing to our newsletters.   5. How Boston Scientific is boosting medical device value Boston Scientific over the summer unveiled a new value-add for its implantable cardio devices: an online Trugevity calculator that lets physicians predict battery life. The...
Source: Mass Device - September 14, 2017 Category: Medical Devices Authors: MassDevice Tags: News Well Plus 5 Source Type: news

Endologix touts Japanese collab dev & distro deal, 1st-in-human Ovation Alto trial data
Endologix (NSDQ:ELGX) this week announced a joint R&D and exclusive distribution deal with Japan Lifeline and released case review results from the 1st-in-human use of its Ovation Alto stent graft designed for endovascular aneurysm repair. The Irvine, Calif.-based company said it inked a deal with Japan Lifeline to jointly invest in development, clinical research and commercialization of novel endovascular stent graft systems for the treatment of thoracic aortic disease. Japan Lifeline will gain exclusive distribution rights to the systems in Japan, while Endologix said it will commercialize the system through its...
Source: Mass Device - September 14, 2017 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Clinical Trials Distribution Research & Development Stents Vascular Endologix Source Type: news

Medtronic touts 5-year gendered sub-analysis data from Endurant AAA stent graft trial
Medtronic (NYSE:MDT) today released new 5-year data from a gender separated subset of the Engage trial of its Endurant II abdominal aortic aneurysm stent graft system. The subset analysis aimed to compare results across both male and female patients. Fridley, Minn.-based Medtronic said that historically, women have had worse EVAR outcomes than men due to anatomy differences, including more angulated aortic necks and smaller aneurysms and iliac vessels. The analysis included 1,263 patients, with 133 female and 1,130 males. For women in the study, data indicated a 99.2% rate of successful delivery and eployment, only 0....
Source: Mass Device - September 13, 2017 Category: Medical Devices Authors: Fink Densford Tags: Clinical Trials Vascular Medtronic Source Type: news

Canadian task force shifts gears on AAA screening
Ultrasound screening for abdominal aortic aneurysms (AAA) may see an uptick...Read more on AuntMinnie.comRelated Reading: USPSTF to take another look at AAA screening SPECT/CT tracer shows promise for AAA risk evaluation Current AAA screening strategies may miss the mark Vascular surgery society cautions use of US in AAA USPSTF finalizes AAA screening recommendations (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - September 11, 2017 Category: Radiology Source Type: news

Does alcohol affect the risk of developing an abdominal aortic aneurysm?
(Wiley) In an analysis of published studies, lower levels of alcohol consumption were associated with a lower risk of abdominal aortic aneurysm until approximately 15 to 20 g/day, with an increasing risk thereafter. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - September 7, 2017 Category: International Medicine & Public Health Source Type: news

' Triple' Screening for AAA, PAD, High BP Reduces Mortality'Triple' Screening for AAA, PAD, High BP Reduces Mortality
Results of the VIVA trial show that a program of three screening tests--for abdominal aortic aneurysm, peripheral arterial disease, and hypertension--resulted in a significant reduction in all-cause mortality at 5 years.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 31, 2017 Category: Consumer Health News Tags: Cardiology News Source Type: news

Screening for vascular disease saves one life for every 169 patients assessed (VIVA)
(European Society of Cardiology) A novel screening program for vascular disease saves one life for every 169 men assessed, according to late-breaking results from the VIVA trial presented today in a Hot Line LBCT Session at ESC Congress and published in the Lancet. The combined screening for abdominal aortic aneurysm, peripheral artery disease, and hypertension gained more living years for lower costs than European cancer screening programs. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 28, 2017 Category: International Medicine & Public Health Source Type: news

UCLA Health hospitals place No. 1 in Los Angeles, No. 7 nationally in prominent ranking
UCLA Health hospitals in Westwood and Santa Monica placed No. 1 in Los Angeles, No. 2 in California and No. 7 in the nation in the 2017 –18 U.S. News and World Report rankings.“UCLA Health is proud to be recognized for providing world-class treatment to patients from greater Los Angeles, across the state and around the globe,” said Johnese Spisso, president ofUCLA Health, CEO of UCLA Hospital System and associate vice chancellor of UCLA Health Sciences. “Our long-standing commitment to excellence ensures that our patients and their families receive the most compassionate, comprehensive care possible...
Source: UCLA Newsroom: Health Sciences - August 8, 2017 Category: Universities & Medical Training Source Type: news

New imaging tracer allows early assessment of abdominal aortic aneurysm risk
(Society of Nuclear Medicine) Yale University researchers have developed a way in which medical imaging with SPECT/CT could potentially be used to assess a patient's rupture risk for abdominal aortic aneurysm. Delaying surgical treatment can be life-threatening, and this new type of imaging could allow physicians to diagnose disease and better plan its management. The study is presented in the featured article of the August issue of The Journal of Nuclear Medicine. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 1, 2017 Category: International Medicine & Public Health Source Type: news

Endologix touts low rate of endoleaks, mortality in 2-year Nellix study results
Endologix (NSDQ:ELGX) today announced the presentation of 2-year data from the EVAS Forward IDE trial of its Nellix stent graft for repairing abdominal aortic aneurysms, touting a high rate of freedom from endoleaks, ruptures and mortalities. Results from the trial were presented by study principal investigator Dr. Jeffrey Carpenter of New Jersey’s Cooper Medical Schoo and Cooper Health System at the Society of Vascular Surgery’s 2017 Vascular annual meeting this week. “The overall 2-year results for EVAS with Nellix are very encouraging. In particular, the refined IFU appears to offer excellent...
Source: Mass Device - June 5, 2017 Category: Medical Devices Authors: Fink Densford Tags: Clinical Trials Stent Grafts Vascular Endologix Source Type: news

7 medtech stories we missed this week: May 19, 2017
[Image from unsplash.com]From FDA clearances to touting study data, here are 7 medtech stories we missed this week but thought were still worth mentioning. 1. XpandOrtho wins FDA 510(k) clearance XpandOrtho announced in a May 17 press release that it has received FDA 510(k) clearance for its electronic soft tissue balancing instrument for total knee replacement surgery. The sterile-packaged wireless disposable device uses miniature sensors and actuators to balance knee joints during full-range motions. Using constant pressure bellows systems, the device communicates with a display for multiaxial balance and selection of th...
Source: Mass Device - May 19, 2017 Category: Medical Devices Authors: Danielle Kirsh Tags: 510(k) Clinical Trials Food & Drug Administration (FDA) Regulatory/Compliance Research & Development Body Vision Medical Exactech Inc. Lombard Medical Technologies MedTech NxThera Inc. Rivanna Medical Visionsense XpandOrtho Source Type: news

MassDevice.com +5 | The top 5 medtech stories for May 18, 2017
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry. Get this in your inbox everyday by subscribing to our newsletters.   5. Medtronic owes spine doc inventor $24m for patent infringement Medtronic must fork over nearly $24 million to the physician inventor behind a group of patents covering a technique for treating spine defects. Dr. Mark Barry sued...
Source: Mass Device - May 18, 2017 Category: Medical Devices Authors: MassDevice Tags: News Well Source Type: news

Endologix dives on 2-year setback for Nellix stent graft
Endologix (NSDQ:ELGX) shares were off more than 30% this morning after the company yesterday revealed a 2-year setback for its Nellix stent graft for repairing abdominal aortic aneurysms. Irvine, Calif.-based Endologix said meetings with the FDA and “further internal analysis” led it to decide to launch a “confirmatory” trial for Nellix, which was initially delayed last November when the federal safety watchdog asked for 2-year follow-up data from the EVAS-Forward investigational device exemption study. Endologix said yesterday that the confirmatory study will aim to cover t...
Source: Mass Device - May 18, 2017 Category: Medical Devices Authors: Brad Perriello Tags: Food & Drug Administration (FDA) Regulatory/Compliance Stent Grafts Wall Street Beat Endologix Source Type: news

MassDevice.com +5 | The top 5 medtech stories for April 26, 2017
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry. Get this in your inbox everyday by subscribing to our newsletters.   5. Baxter sees shares lift on Street-beating Q1 earnings release Baxter shares have risen today after the medical device company topped expectations on Wall Street with its 1st quarter earnings results. The Deerfield, Ill.-based c...
Source: Mass Device - April 26, 2017 Category: Medical Equipment Authors: MassDevice Tags: News Well Plus 5 Source Type: news

Medtronic touts 5-year Endurant II AAA registry data
Medtronic (NYSE:MDT) today released 5-year data from the Engage global registry study of its Endurant II abdominal aortic aneurysm stent graft, touting long-term durability and consistent outcomes with the device. Results from the study, which the company claims is the most robust post-market registry of endovascular aortic repairs to date, was presented at the 2017 Charing Cross Symposium in London this week. “Medtronic aims to increase access to treatment for patients with aortic disease. This goal has been reinforced by our commitment to developing robust clinical programs – such as the Engage registry &ndas...
Source: Mass Device - April 26, 2017 Category: Medical Equipment Authors: Fink Densford Tags: Clinical Trials Endoscopic / Arthroscopic Stent Grafts Vascular Medtronic Source Type: news

Women Fare Poorly With Aortic Aneurysm: Study
WEDNESDAY, April 26, 2017 -- Women with abdominal aortic aneurysms have far worse outcomes than men, and their treatment needs to be dramatically improved, British researchers report. An abdominal aortic aneurysm occurs when there is weakening and... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - April 26, 2017 Category: Journals (General) Source Type: news

Women with aortic aneurysms fare much worse than men, new study finds
(Imperial College London) Mortality rates for women undergoing surgery for abdominal aortic aneurysms are nearly twice those for men, a new study has found. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - April 25, 2017 Category: Global & Universal Source Type: news

MassDevice.com +5 | The top 5 medtech stories for April 5, 2017
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry. Get this in your inbox everyday by subscribing to our newsletters.   5. Trumpcare’s prospects dim, but not too dim to hit stent graft makers The push on Capitol Hill to revive Trumpcare stalled yesterday, but not before the chatter out of Washington instigated a slide for stent graft makers&r...
Source: Mass Device - April 5, 2017 Category: Medical Equipment Authors: MassDevice Tags: News Well Plus 5 Source Type: news

Trumpcare ’ s prospects dim, but not too dim to hit stent graft makers
The push on Capitol Hill to revive Trumpcare stalled yesterday, but not before the chatter out of Washington instigated a slide for stent graft makers’ stocks. The Affordable Care Act covers a 1-time screening for abdominal aortic aneurysms in men who smoke or smoked in the past, listing the test as an “essential health benefit.” The GOP’s healthcare reform proposal would do away with the AAA screening coverage, shifting the cost of the test to patients, which could in turn affect AAA repair procedure volumes. Investors reacted by pushing share prices down yesterday on Wall Street for Lombard M...
Source: Mass Device - April 5, 2017 Category: Medical Equipment Authors: Brad Perriello Tags: Healthcare Reform Stent Grafts Wall Street Beat C.R. Bard Capitol Hill Endologix Lombard Medical Technologies Source Type: news

7 medtech stories we missed this week: March 31, 2017
[Image from unsplash.com]This week we saw a few FDA 510(k) clearances and one of the 1st uses of a next-generation surgical robot in Asia. Here are 7 medtech stories we missed this week but thought were still worth mentioning: 1. Corindus touts first Asian use of next-generation robot Corindus Vascular Robotics announced in a March 31 press release that robot-assisted PCI procedures were performed for the first time in Asia using the CorPath GRX system. The procedures were performed at Fu Wai Hospital. This is the first time the system has been used outside of the U.S. CorPath GRX enhances the precision and workflow of the...
Source: Mass Device - March 31, 2017 Category: Medical Equipment Authors: Danielle Kirsh Tags: Clinical Trials Food & Drug Administration (FDA) Robot-Assisted Surgery Robotics Stent Grafts Amniox Bodycad Corindus Endologix MedTech NeoSurgical NeoTract Providence Medical Tissuetech Source Type: news

Moderate drinking may reduce heart disease risk
Conclusion This study paints a more complicated picture than the "Pint a day keeps the doctor away" story proffered by The Sun. It seems to confirm the findings of other studies, which have shown that non-drinkers tend to have a higher risk of cardiovascular diseases than people who drink moderately. It suggests that some cardiovascular diseases (mainly those directly affecting the heart) seem to have a stronger link to a possible protective effect from alcohol than other vascular diseases, such as mini-strokes and bleeding in the brain. However, this can't be concluded with certainty due to the study design. We ...
Source: NHS News Feed - March 23, 2017 Category: Consumer Health News Tags: Heart/lungs Food/diet Lifestyle/exercise Source Type: news

Endologix faces shareholder suit over Nellix snafu
Endologix (NSDQ:ELGX) is facing a lawsuit from stockholders alleging the company miscommunicated and failed to disclose issues related to its Nellix EVAS stent graft designed for treating abdominal aortic aneurysms. The shareholders filed the suit in the US District Court for the Central District of California, representing individuals who purchased shares between Aug. 2, 2016 and Nov. 16, 2016, according to an SEC filing. The suing shareholders allege that the company made “materially false and misleading statements and failed to disclose material adverse facts about its business, operational and financial perf...
Source: Mass Device - March 3, 2017 Category: Medical Equipment Authors: Fink Densford Tags: Business/Financial News Legal News Endologix Inc. Source Type: news

MicroPort, undaunted by price caps, enters India ’ s stent market
MicroPort has entered the Indian market only days after the country’s National Pharmaceutical Pricing Authority imposed a price cap on coronary stents. The Shanghai-based company said its Firehawk Rapamycin target eluting coronary stent system was successfully used in a procedure in Mumbai earlier in the month, marking the 1st time the device saw use in the country. The procedure was performed at H. J. Doshi Ghatkopar Hindu Sabha Hospital in Mumbai, by Dr. Anil Potdar, according to a press release. The company touted the Indian market as having the 3rd largest amount of PCI cases in the world, and promised future exp...
Source: Mass Device - February 28, 2017 Category: Medical Equipment Authors: Fink Densford Tags: Business/Financial News Cardiac Implants Cardiovascular Stents MicroPort Scientific Source Type: news

Endologix wins CE Mark reinstatement for AFX, AFX2, touts 3-year post market Ovation study
This study confirms the ability of the Ovation platform to successfully treat a broad array of patient anatomies with a high rate of treatment success and freedom from secondary intervention through mid-term follow-up. We are pleased to have revealed these impressive results at our scientific symposium this year,” study principal investigator Dr. Dierk Scheinert said in a prepared statement. “The addition of these European results continue to validate the excellent clinical results and durability of the ultra-low profile Ovation platform, further confirming the recently announced 5-year Ovation IDE study r...
Source: Mass Device - January 25, 2017 Category: Medical Equipment Authors: Fink Densford Tags: Clinical Trials Regulatory/Compliance Vascular Endologix Inc. Source Type: news

Endologix cuts outlook for 2017
Endologix is reportedly lowering its revenue growth outlook to flat- to low-single digits. The company has previously said it expects mid-single digit growth for 2017. The Irvine, Calif.-based company’s management commented on Endologix’s outlook at the 35th JP Morgan Healthcare Conference, according to a report from Leerink. The company has not made a formal statement regarding its guidance for 2017. The analyst wrote that Endologix is probably going to see further downward estimate revisions, especially given the regulatory and quality issues that came to light in December last year. The compan...
Source: Mass Device - January 11, 2017 Category: Medical Equipment Authors: Sarah Faulkner Tags: MassDevice Earnings Roundup Vascular Wall Street Beat Endologix Inc. Source Type: news

Lombard wins Japanese clearance for IntelliFlex LP delivery device for Aorfix stent graft
Lombard Medical Technologies (NSDQ:EVAR) said today it won approval from the Japanese Ministry of Health, Labour and Welfare for its Intelliflex low profile delivery system for the Aorfix endovascular stent graft. The Oxfordshire, England-based company said it will initiate a commercial launch of the device in Japan once it receives reimbursement approval, expected some time next month. Currently, Medico’s Hirata has exclusive distribution rights to the Aorfix. “We have enjoyed great success already with Aorfix in Japan and built our market share to approximately 8% over the last two years. Now with t...
Source: Mass Device - January 5, 2017 Category: Medical Equipment Authors: Fink Densford Tags: Catheters Regulatory/Compliance Vascular Lombard Medical Technologies Source Type: news

MassDevice.com +5 | The top 5 medtech stories for December 28, 2016
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry. Get this in your inbox everyday by subscribing to our newsletters.   5. Precision Spine wins FDA 510(k) for AccuFit lateral plate system Precision Spine said today it won FDA 510(k) clearance for its AccuFit lateral plating system designed to treat spinal instability. The Parsippany, N.J.-based com...
Source: Mass Device - December 28, 2016 Category: Medical Equipment Authors: MassDevice Tags: News Well Plus 5 Source Type: news

Endologix puts hold on AFX shipments over manufacturing issues
Endologix (NSDQ:ELGX) said today it is temporarily holding shipments of its AFX Endovascular abdominal aortic aneurysm system as it completes an investigation of manufacturing issues with the devices. The AFX system is designed to provide anatomical fixation to treat a wide range of AAA anatomies, according to the company. The hold came only weeks after Endologix had the CE Mark approval for the AFX system suspended over reports of type III endoleaks associated with a previous-gen version of the device. The Irvine, Calif.-based company expects the temporary hold to be lifted for some sizes “in the near future,&r...
Source: Mass Device - December 27, 2016 Category: Medical Equipment Authors: Fink Densford Tags: Business/Financial News Regulatory/Compliance Vascular Endologix Inc. Source Type: news

China ’ s Microport puts $15m into Lombard Medical
Lombard Medical Technologies (NSDQ:EVAR) said today that China’s MicroPort Orthopedics invested $15 million as part of a partnership deal between the 2 companies. Through the partnership, Lombard will seek to accelerate commercialization of its Arofix and Altura stent grafts for treating abdominal aortic aneurysms. Microport will gain exclusive marketing rights for both products in China and Brazil, as well as a license to manufacture the products for the Chinese market. As part of the deal, Microport and Lombard said they entered a component supply manufacturing deal, with Microport manufacturing comp...
Source: Mass Device - December 19, 2016 Category: Medical Equipment Authors: Fink Densford Tags: Mergers & Acquisitions Stent Grafts Vascular Lombard Medical Technologies MicroPort Scientific Source Type: news

MassDevice.com +5 | The top 5 medtech stories for December 13, 2016
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry. Get this in your inbox everyday by subscribing to our newsletters.   5. Defymed partners with Semma Therapeutics on bio-artificial pancreas French biotech developer Defymed said today it inked a collaborative deal with American biotech company Semma Therapeutics to support the continued development...
Source: Mass Device - December 13, 2016 Category: Medical Equipment Authors: MassDevice Tags: News Well Plus 5 Source Type: news

Endologix AFX CE Mark suspended over endoleak issues
Endologix (NSDQ:ELGX) said yesterday that the CE Mark approval of its AFX abdominal aortic aneurysm system will be suspended over reports of type III endoleaks with a previous-gen version of the device. The AFX system is designed to provide anatomical fixation to treat a wide range of AAA anatomies, according to the company. The Irvine, Calif.-based company said it has implemented “device and graft material improvements and updated instructions for use resulting in a substantial reduction in reported type III endoleaks,” according to an SEC filing. Endologix said it has received no reports of type III...
Source: Mass Device - December 13, 2016 Category: Medical Equipment Authors: Fink Densford Tags: Blog Endologix Inc. Source Type: news

Report looks at the health of the 'baby boomer' generation
Conclusion The baby boomer generation represents the first generation of babies to have grown up with the NHS (founded in 1948). Thankfully, health issues such as death during childbirth, high levels of child mortality and high rates of fatal infectious diseases, such as tuberculosis, are largely a thing of a past. But new challenges have arisen. So-called "lifestyle diseases" such as type 2 diabetes and heart disease, are now a leading cause of death in England (as well as other developed countries). Also, age-related conditions such as dementia are far more common than in previous decades. Everyone can improve...
Source: NHS News Feed - December 9, 2016 Category: Consumer Health News Tags: QA articles Older people Source Type: news

MassDevice.com +5 | The top 5 medtech stories for December 6, 2016
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry. Get this in your inbox everyday by subscribing to our newsletters.   5. MedyMatch looks to future of stroke detection with AI platform launch Artificial intelligence healthcare startup MedyMatch Technology said late last month its AI platform designed to detect intracranial hemorrhage or brain blee...
Source: Mass Device - December 6, 2016 Category: Medical Equipment Authors: MassDevice Tags: News Well Plus 5 Source Type: news

Medtronic wins expanded CE Mark indication for Endurant II stent graft
Medtronic (NYSE:MDT) said today that it won an expanded CE Mark indication in the European Union for its Endurant II/IIs stent graft for treating abdominal aortic aneurysms. The expanded indication covers a new endovascular implantation approach using a parallel graft chimney approach called ChEVAR, which allows the device to be used to treat aneurysms with an aortic neck length of 2mm or more. Aortic neck length is the distance from the renal arteries to the aneurysm. The ChEVAR approach, which uses balloon-expandable covered stents in the renal arteries and a stent graft in the aorta, is designed to increase the infraren...
Source: Mass Device - December 6, 2016 Category: Medical Equipment Authors: Brad Perriello Tags: Endoscopic / Arthroscopic Regulatory/Compliance Stent Grafts Medtronic Source Type: news

PodMed: A Medical News Roundup From Johns Hopkins (with audio)
(MedPage Today) -- This week's topics include blood pressure lowering meds and fracture, LASIK surgery outcomes, treatment of abdominal aortic aneurysm, and measles and mumps outbreaks. (Source: MedPage Today Pediatrics)
Source: MedPage Today Pediatrics - November 26, 2016 Category: Pediatrics Source Type: news

Abdominal aortic aneurysm: Death rate from burst vessels THREE times higher in UK than US
THREE times as many people died from abdominal aortic aneurysms in England than in the US, which researchers have suggested could be due to a lower operation rate in England. (Source: Daily Express - Health)
Source: Daily Express - Health - November 24, 2016 Category: Consumer Health News Source Type: news

AAA: Earlier Repair, Fewer Ruptures in US Than England AAA: Earlier Repair, Fewer Ruptures in US Than England
Thresholds for repair of abdominal aortic aneurysms are lower in the United States than England, and rates of aneurysm rupture and aneurysm-related death are also lower.Medscape Medical News (Source: Medscape Radiology Headlines)
Source: Medscape Radiology Headlines - November 23, 2016 Category: Radiology Tags: General Surgery News Source Type: news

MassDevice.com +5 | The top 5 medtech stories for November 21, 2016
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry. Get this in your inbox everyday by subscribing to our newsletters.   5. Zimmer Biomet readies $1B tenders for senior debt Zimmer Biomet said today that it plans to float tender offers for some $1.1 billion worth of senior notes. The tenders are aimed at lowering the debt load it took on when Zimmer...
Source: Mass Device - November 21, 2016 Category: Medical Equipment Authors: MassDevice Tags: News Well Plus 5 Source Type: news

Veith 2016 Roundup: Stent grafts take center stage
Medtronic touts Endurant stent graft data from Engage study Medtronic (NYSE:MDT) touted data from a series of sub-group analyses from the 10-year 1,200-patient Engage study of its Endurant II and Endurant IIs stent grafts for treating abdominal aortic aneurysms last week at the annual Veith Symposium on vascular disease. First-time results from a review of the occurrence of endoleaks at the aneurysm neck, presented by Dr. Hence Verhagen of Erasmus University Medical Center in Rotterdam, Holland, showed a 97.8% rate of freedom from Type Ia endoleaks at 1 year. The rate was 97.3% at 2, 96.7% at 3 years and 96%...
Source: Mass Device - November 21, 2016 Category: Medical Equipment Authors: Brad Perriello Tags: Stent Grafts Stents Vascular Biotronik Endologix Inc. Medtronic Veith Symposium 2016 W.L. Gore & Associates Source Type: news

Smokers Have Higher Lifetime Risk of Abdominal Aortic Aneurysm Smokers Have Higher Lifetime Risk of Abdominal Aortic Aneurysm
Smokers could be doubling their risk for abdominal aortic aneurysm (AAA), researchers say.Reuters Health Information (Source: Medscape Radiology Headlines)
Source: Medscape Radiology Headlines - November 17, 2016 Category: Radiology Tags: News Source Type: news

Smokers have higher lifetime risk of abdominal aortic aneurysm
This study adds to the literature by reporting AAA lifetime risk from a community-based cohort with long follow-up,” Tang told Reuters Health by email. The researchers used data from more than 15,000 middle-aged people who were at risk of developing AAA based on an initial assessment between 1987 and 1989. The participants made three subsequent visits for exams and assessments through 1998. Nearly 6,000 people were still alive between 2011 and 2013 and underwent an ultrasound exam at a fifth assessment visit then. Over the 22-year follow-up period, there were 590 diagnosed, ruptured or repaired AAAs. In 2011, the ult...
Source: Mass Device - November 17, 2016 Category: Medical Equipment Authors: MassDevice Tags: Vascular Source Type: news

Smokers have higher lifetime risk of abdominal aortic aneurysm
(Reuters Health) – - Smokers could be doubling their risk for a type of aneurysm that is usually fatal if it ruptures, researchers say. (Source: Reuters: Health)
Source: Reuters: Health - November 16, 2016 Category: Consumer Health News Tags: healthNews Source Type: news